 | • レポートコード：QAF27812 • 出版社/出版日：QYResearch / 2021年4月5日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、149ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の口腔粘膜炎治療薬市場について種類別（うがい薬、鎮痛薬、その他）、用途別（化学療法、放射線療法）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・口腔粘膜炎治療薬市場の概要 ・世界の主要地域別口腔粘膜炎治療薬市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の口腔粘膜炎治療薬市場規模2016-2021：種類別（うがい薬、鎮痛薬、その他） ・世界の口腔粘膜炎治療薬市場予測2012-2027：種類別（うがい薬、鎮痛薬、その他） ・世界の口腔粘膜炎治療薬市場規模2016-2021：用途別（化学療法、放射線療法） ・世界の口腔粘膜炎治療薬市場予測2012-2027：用途別（化学療法、放射線療法） ・口腔粘膜炎治療薬のアメリカ市場規模と予測2016-2021 ・口腔粘膜炎治療薬のヨーロッパ市場規模と予測2016-2021 ・口腔粘膜炎治療薬の中国市場規模と予測2016-2021 ・口腔粘膜炎治療薬の日本市場規模と予測2016-2021 ・口腔粘膜炎治療薬の東南アジア市場規模と予測2016-2021 ・口腔粘膜炎治療薬のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （3M Healthcare、GSK、Pfizer、Colgate-Palmolive、Norgine、Sobi、Bausch Health、EUSA Pharma、Camurus、Clinigen Group、Helsinn Healthcare、Alliance Pharma） ・口腔粘膜炎治療薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・口腔粘膜炎治療薬の市場動向・機会・課題 ・調査の結論 |
Oral mucositis is the most common complication of chemotherapy, and occurs usually in the people suffering from head and neck cancer. It causes damage to mucosal lining of the mouth which results in formation of ulcers and infections. The disease occurs usually occurs after 5 to 10 days of a chemotherapy process in cancer patients. Oral mucositis leads to different problems such as severe pain in mouth, lack of nutrition due to inability to eat, increased risk of infections due to open sores in the oral cavity. The disease usually lasts for one week to six weeks or more.
The classification of Oral Mucositis Drugs includes Mouthwash, Pain Control Medication and Other, the Pain Control Medication with a market share of 65.02%. The market share of Mouthwash is 19.60% in 2019.
Oral Mucositis Drugs is widely used to Chemotherapy Oral Mucositis and Radiotherapy Oral Mucositis. The most proportion of Oral Mucositis Drugs is to Radiotherapy Oral Mucositis, and the proportion is about 68.25% in 2019.
America is the largest market, with a consumption market share nearly 53% in 2019. Following America, Europe is the second largest sales place with the sales market share of 27% in 2019. China is an important market of Oral Mucositis Drugs in Asia, accounting for 7.3% market share of global market.
3M Healthcare, GSK, Pfizer, Colgate-Palmolive, Norgine are the leaders of the industry, and hold key technologies and patents. Other manufactures’ products are used to meet local demand. With further expanding market, there will be more players in the future.
Market Analysis and Insights: Global Oral Mucositis Drugs Market
The global Oral Mucositis Drugs market was valued at US$ 887.9 in 2020 and will reach US$ 1370.3 million by the end of 2027, growing at a CAGR of 7.5% during 2022-2027.
Global Oral Mucositis Drugs Scope and Market Size
The global Oral Mucositis Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oral Mucositis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Mouthwash
Pain Control Medication
Other
Segment by Application
Chemotherapy
Radiotherapy
The Oral Mucositis Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Oral Mucositis Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
3M Healthcare
GSK
Pfizer
Colgate-Palmolive
Norgine
Sobi
Bausch Health
EUSA Pharma
Camurus
Clinigen Group
Helsinn Healthcare
Alliance Pharma
1 Oral Mucositis Drugs Market Overview
1.1 Oral Mucositis Drugs Product Scope
1.2 Oral Mucositis Drugs Segment by Type
1.2.1 Global Oral Mucositis Drugs Sales by Type (2016 & 2021 & 2027)
1.2.2 Mouthwash
1.2.3 Pain Control Medication
1.2.4 Other
1.3 Oral Mucositis Drugs Segment by Application
1.3.1 Global Oral Mucositis Drugs Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Chemotherapy
1.3.3 Radiotherapy
1.4 Oral Mucositis Drugs Market Estimates and Forecasts (2016-2027)
1.4.1 Global Oral Mucositis Drugs Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Oral Mucositis Drugs Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Oral Mucositis Drugs Price Trends (2016-2027)
2 Oral Mucositis Drugs Estimates and Forecasts by Region
2.1 Global Oral Mucositis Drugs Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Oral Mucositis Drugs Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Oral Mucositis Drugs Sales Market Share by Region (2016-2021)
2.2.2 Global Oral Mucositis Drugs Revenue Market Share by Region (2016-2021)
2.3 Global Oral Mucositis Drugs Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Oral Mucositis Drugs Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Oral Mucositis Drugs Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Oral Mucositis Drugs Estimates and Projections (2016-2027)
2.4.2 Europe Oral Mucositis Drugs Estimates and Projections (2016-2027)
2.4.3 China Oral Mucositis Drugs Estimates and Projections (2016-2027)
2.4.4 Japan Oral Mucositis Drugs Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Oral Mucositis Drugs Estimates and Projections (2016-2027)
2.4.6 India Oral Mucositis Drugs Estimates and Projections (2016-2027)
3 Global Oral Mucositis Drugs Competition Landscape by Players
3.1 Global Top Oral Mucositis Drugs Players by Sales (2016-2021)
3.2 Global Top Oral Mucositis Drugs Players by Revenue (2016-2021)
3.3 Global Oral Mucositis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Mucositis Drugs as of 2020)
3.4 Global Oral Mucositis Drugs Average Price by Company (2016-2021)
3.5 Manufacturers Oral Mucositis Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Oral Mucositis Drugs Market Size by Type
4.1 Global Oral Mucositis Drugs Historic Market Review by Type (2016-2021)
4.1.1 Global Oral Mucositis Drugs Sales Market Share by Type (2016-2021)
4.1.2 Global Oral Mucositis Drugs Revenue Market Share by Type (2016-2021)
4.1.3 Global Oral Mucositis Drugs Price by Type (2016-2021)
4.2 Global Oral Mucositis Drugs Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Oral Mucositis Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Oral Mucositis Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Global Oral Mucositis Drugs Price Forecast by Type (2022-2027)
5 Global Oral Mucositis Drugs Market Size by Application
5.1 Global Oral Mucositis Drugs Historic Market Review by Application (2016-2021)
5.1.1 Global Oral Mucositis Drugs Sales Market Share by Application (2016-2021)
5.1.2 Global Oral Mucositis Drugs Revenue Market Share by Application (2016-2021)
5.1.3 Global Oral Mucositis Drugs Price by Application (2016-2021)
5.2 Global Oral Mucositis Drugs Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Oral Mucositis Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Oral Mucositis Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Oral Mucositis Drugs Price Forecast by Application (2022-2027)
6 North America Oral Mucositis Drugs Market Facts & Figures
6.1 North America Oral Mucositis Drugs Sales by Company
6.1.1 North America Oral Mucositis Drugs Sales by Company (2016-2021)
6.1.2 North America Oral Mucositis Drugs Revenue by Company (2016-2021)
6.2 North America Oral Mucositis Drugs Sales Breakdown by Type
6.2.1 North America Oral Mucositis Drugs Sales Breakdown by Type (2016-2021)
6.2.2 North America Oral Mucositis Drugs Sales Breakdown by Type (2022-2027)
6.3 North America Oral Mucositis Drugs Sales Breakdown by Application
6.3.1 North America Oral Mucositis Drugs Sales Breakdown by Application (2016-2021)
6.3.2 North America Oral Mucositis Drugs Sales Breakdown by Application (2022-2027)
7 Europe Oral Mucositis Drugs Market Facts & Figures
7.1 Europe Oral Mucositis Drugs Sales by Company
7.1.1 Europe Oral Mucositis Drugs Sales by Company (2016-2021)
7.1.2 Europe Oral Mucositis Drugs Revenue by Company (2016-2021)
7.2 Europe Oral Mucositis Drugs Sales Breakdown by Type
7.2.1 Europe Oral Mucositis Drugs Sales Breakdown by Type (2016-2021)
7.2.2 Europe Oral Mucositis Drugs Sales Breakdown by Type (2022-2027)
7.3 Europe Oral Mucositis Drugs Sales Breakdown by Application
7.3.1 Europe 149 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 149 Sales Breakdown by Application (2022-2027)
8 China Oral Mucositis Drugs Market Facts & Figures
8.1 China Oral Mucositis Drugs Sales by Company
8.1.1 China Oral Mucositis Drugs Sales by Company (2016-2021)
8.1.2 China Oral Mucositis Drugs Revenue by Company (2016-2021)
8.2 China Oral Mucositis Drugs Sales Breakdown by Type
8.2.1 China Oral Mucositis Drugs Sales Breakdown by Type (2016-2021)
8.2.2 China Oral Mucositis Drugs Sales Breakdown by Type (2022-2027)
8.3 China Oral Mucositis Drugs Sales Breakdown by Application
8.3.1 China 312 Sales Breakdown by Application (2016-2021)
8.3.2 China 312 Sales Breakdown by Application (2022-2027)
9 Japan Oral Mucositis Drugs Market Facts & Figures
9.1 Japan Oral Mucositis Drugs Sales by Company
9.1.1 Japan Oral Mucositis Drugs Sales by Company (2016-2021)
9.1.2 Japan Oral Mucositis Drugs Revenue by Company (2016-2021)
9.2 Japan Oral Mucositis Drugs Sales Breakdown by Type
9.2.1 Japan Oral Mucositis Drugs Sales Breakdown by Type (2016-2021)
9.2.2 Japan Oral Mucositis Drugs Sales Breakdown by Type (2022-2027)
9.3 Japan Oral Mucositis Drugs Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Oral Mucositis Drugs Market Facts & Figures
10.1 Southeast Asia Oral Mucositis Drugs Sales by Company
10.1.1 Southeast Asia Oral Mucositis Drugs Sales by Company (2016-2021)
10.1.2 Southeast Asia Oral Mucositis Drugs Revenue by Company (2016-2021)
10.2 Southeast Asia Oral Mucositis Drugs Sales Breakdown by Type
10.2.1 Southeast Asia Oral Mucositis Drugs Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Oral Mucositis Drugs Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Oral Mucositis Drugs Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Oral Mucositis Drugs Market Facts & Figures
11.1 India Oral Mucositis Drugs Sales by Company
11.1.1 India Oral Mucositis Drugs Sales by Company (2016-2021)
11.1.2 India Oral Mucositis Drugs Revenue by Company (2016-2021)
11.2 India Oral Mucositis Drugs Sales Breakdown by Type
11.2.1 India Oral Mucositis Drugs Sales Breakdown by Type (2016-2021)
11.2.2 India Oral Mucositis Drugs Sales Breakdown by Type (2022-2027)
11.3 India Oral Mucositis Drugs Sales Breakdown by Application
11.3.1 India Oral Mucositis Drugs Sales Breakdown by Application (2016-2021)
11.3.2 India Oral Mucositis Drugs Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Oral Mucositis Drugs Business
12.1 3M Healthcare
12.1.1 3M Healthcare Corporation Information
12.1.2 3M Healthcare Business Overview
12.1.3 3M Healthcare Oral Mucositis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 3M Healthcare Oral Mucositis Drugs Products Offered
12.1.5 3M Healthcare Recent Development
12.2 GSK
12.2.1 GSK Corporation Information
12.2.2 GSK Business Overview
12.2.3 GSK Oral Mucositis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 GSK Oral Mucositis Drugs Products Offered
12.2.5 GSK Recent Development
12.3 Pfizer
12.3.1 Pfizer Corporation Information
12.3.2 Pfizer Business Overview
12.3.3 Pfizer Oral Mucositis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Pfizer Oral Mucositis Drugs Products Offered
12.3.5 Pfizer Recent Development
12.4 Colgate-Palmolive
12.4.1 Colgate-Palmolive Corporation Information
12.4.2 Colgate-Palmolive Business Overview
12.4.3 Colgate-Palmolive Oral Mucositis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Colgate-Palmolive Oral Mucositis Drugs Products Offered
12.4.5 Colgate-Palmolive Recent Development
12.5 Norgine
12.5.1 Norgine Corporation Information
12.5.2 Norgine Business Overview
12.5.3 Norgine Oral Mucositis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Norgine Oral Mucositis Drugs Products Offered
12.5.5 Norgine Recent Development
12.6 Sobi
12.6.1 Sobi Corporation Information
12.6.2 Sobi Business Overview
12.6.3 Sobi Oral Mucositis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Sobi Oral Mucositis Drugs Products Offered
12.6.5 Sobi Recent Development
12.7 Bausch Health
12.7.1 Bausch Health Corporation Information
12.7.2 Bausch Health Business Overview
12.7.3 Bausch Health Oral Mucositis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Bausch Health Oral Mucositis Drugs Products Offered
12.7.5 Bausch Health Recent Development
12.8 EUSA Pharma
12.8.1 EUSA Pharma Corporation Information
12.8.2 EUSA Pharma Business Overview
12.8.3 EUSA Pharma Oral Mucositis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 EUSA Pharma Oral Mucositis Drugs Products Offered
12.8.5 EUSA Pharma Recent Development
12.9 Camurus
12.9.1 Camurus Corporation Information
12.9.2 Camurus Business Overview
12.9.3 Camurus Oral Mucositis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Camurus Oral Mucositis Drugs Products Offered
12.9.5 Camurus Recent Development
12.10 Clinigen Group
12.10.1 Clinigen Group Corporation Information
12.10.2 Clinigen Group Business Overview
12.10.3 Clinigen Group Oral Mucositis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Clinigen Group Oral Mucositis Drugs Products Offered
12.10.5 Clinigen Group Recent Development
12.11 Helsinn Healthcare
12.11.1 Helsinn Healthcare Corporation Information
12.11.2 Helsinn Healthcare Business Overview
12.11.3 Helsinn Healthcare Oral Mucositis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Helsinn Healthcare Oral Mucositis Drugs Products Offered
12.11.5 Helsinn Healthcare Recent Development
12.12 Alliance Pharma
12.12.1 Alliance Pharma Corporation Information
12.12.2 Alliance Pharma Business Overview
12.12.3 Alliance Pharma Oral Mucositis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Alliance Pharma Oral Mucositis Drugs Products Offered
12.12.5 Alliance Pharma Recent Development
13 Oral Mucositis Drugs Manufacturing Cost Analysis
13.1 Oral Mucositis Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Oral Mucositis Drugs
13.4 Oral Mucositis Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Oral Mucositis Drugs Distributors List
14.3 Oral Mucositis Drugs Customers
15 Market Dynamics
15.1 Oral Mucositis Drugs Market Trends
15.2 Oral Mucositis Drugs Drivers
15.3 Oral Mucositis Drugs Market Challenges
15.4 Oral Mucositis Drugs Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Oral Mucositis Drugs Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Oral Mucositis Drugs Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Oral Mucositis Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Oral Mucositis Drugs Sales (K Units) by Region (2016-2021)
Table 5. Global Oral Mucositis Drugs Sales Market Share by Region (2016-2021)
Table 6. Global Oral Mucositis Drugs Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Oral Mucositis Drugs Revenue Share by Region (2016-2021)
Table 8. Global Oral Mucositis Drugs Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Oral Mucositis Drugs Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Oral Mucositis Drugs Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Oral Mucositis Drugs Revenue Share Forecast by Region (2022-2027)
Table 12. Global Oral Mucositis Drugs Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Oral Mucositis Drugs Sales Share by Company (2016-2021)
Table 14. Global Oral Mucositis Drugs Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Oral Mucositis Drugs Revenue Share by Company (2016-2021)
Table 16. Global Oral Mucositis Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Mucositis Drugs as of 2020)
Table 17. Global Oral Mucositis Drugs Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Oral Mucositis Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Oral Mucositis Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Oral Mucositis Drugs Sales (K Units) by Type (2016-2021)
Table 22. Global Oral Mucositis Drugs Sales Share by Type (2016-2021)
Table 23. Global Oral Mucositis Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Oral Mucositis Drugs Price (USD/Unit) by Type (2016-2021)
Table 25. Global Oral Mucositis Drugs Sales Share by Type (2022-2027)
Table 26. Global Oral Mucositis Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Oral Mucositis Drugs Revenue Share by Type (2022-2027)
Table 28. Global Oral Mucositis Drugs Price (USD/Unit) by Type (2022-2027)
Table 29. Global Oral Mucositis Drugs Sales (K Units) by Application (2016-2021)
Table 30. Global Oral Mucositis Drugs Sales Share by Application (2016-2021)
Table 31. Global Oral Mucositis Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Oral Mucositis Drugs Price (USD/Unit) by Application (2016-2021)
Table 33. Global Oral Mucositis Drugs Sales (K Units) by Application (2022-2027)
Table 34. Global Oral Mucositis Drugs Sales Share by Application (2022-2027)
Table 35. Global Oral Mucositis Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Oral Mucositis Drugs Revenue Share by Application (2022-2027)
Table 37. Global Oral Mucositis Drugs Price (USD/Unit) by Application (2022-2027)
Table 38. North America Oral Mucositis Drugs Sales (K Units) by Company (2016-2021)
Table 39. North America Oral Mucositis Drugs Sales Market Share by Company (2016-2021)
Table 40. North America Oral Mucositis Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Oral Mucositis Drugs Revenue Market Share by Company (2016-2021)
Table 42. North America Oral Mucositis Drugs Sales by Type (2016-2021) & (K Units)
Table 43. North America Oral Mucositis Drugs Sales Market Share by Type (2016-2021)
Table 44. North America Oral Mucositis Drugs Sales by Type (2022-2027) & (K Units)
Table 45. North America Oral Mucositis Drugs Sales Market Share by Type (2022-2027)
Table 46. North America Oral Mucositis Drugs Sales by Application (2016-2021) & (K Units)
Table 47. North America Oral Mucositis Drugs Sales Market Share by Application (2016-2021)
Table 48. North America Oral Mucositis Drugs Sales by Application (2022-2027) & (K Units)
Table 49. North America Oral Mucositis Drugs Sales Market Share by Application (2022-2027)
Table 50. Europe Oral Mucositis Drugs Sales (K Units) by Company (2016-2021)
Table 51. Europe Oral Mucositis Drugs Sales Market Share by Company (2016-2021)
Table 52. Europe Oral Mucositis Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Oral Mucositis Drugs Revenue Market Share by Company (2016-2021)
Table 54. Europe Oral Mucositis Drugs Sales by Type (2016-2021) & (K Units)
Table 55. Europe Oral Mucositis Drugs Sales Market Share by Type (2016-2021)
Table 56. Europe Oral Mucositis Drugs Sales by Type (2022-2027) & (K Units)
Table 57. Europe Oral Mucositis Drugs Sales Market Share by Type (2022-2027)
Table 58. Europe Oral Mucositis Drugs Sales by Application (2016-2021) & (K Units)
Table 59. Europe Oral Mucositis Drugs Sales Market Share by Application (2016-2021)
Table 60. Europe Oral Mucositis Drugs Sales by Application (2022-2027) & (K Units)
Table 61. Europe Oral Mucositis Drugs Sales Market Share by Application (2022-2027)
Table 62. China Oral Mucositis Drugs Sales (K Units) by Company (2016-2021)
Table 63. China Oral Mucositis Drugs Sales Market Share by Company (2016-2021)
Table 64. China Oral Mucositis Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Oral Mucositis Drugs Revenue Market Share by Company (2016-2021)
Table 66. China Oral Mucositis Drugs Sales by Type (2016-2021) & (K Units)
Table 67. China Oral Mucositis Drugs Sales Market Share by Type (2016-2021)
Table 68. China Oral Mucositis Drugs Sales by Type (2022-2027) & (K Units)
Table 69. China Oral Mucositis Drugs Sales Market Share by Type (2022-2027)
Table 70. China Oral Mucositis Drugs Sales by Application (2016-2021) & (K Units)
Table 71. China Oral Mucositis Drugs Sales Market Share by Application (2016-2021)
Table 72. China Oral Mucositis Drugs Sales by Application (2022-2027) & (K Units)
Table 73. China Oral Mucositis Drugs Sales Market Share by Application (2022-2027)
Table 74. Japan Oral Mucositis Drugs Sales (K Units) by Company (2016-2021)
Table 75. Japan Oral Mucositis Drugs Sales Market Share by Company (2016-2021)
Table 76. Japan Oral Mucositis Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Oral Mucositis Drugs Revenue Market Share by Company (2016-2021)
Table 78. Japan Oral Mucositis Drugs Sales by Type (2016-2021) & (K Units)
Table 79. Japan Oral Mucositis Drugs Sales Market Share by Type (2016-2021)
Table 80. Japan Oral Mucositis Drugs Sales by Type (2022-2027) & (K Units)
Table 81. Japan Oral Mucositis Drugs Sales Market Share by Type (2022-2027)
Table 82. Japan Oral Mucositis Drugs Sales by Application (2016-2021) & (K Units)
Table 83. Japan Oral Mucositis Drugs Sales Market Share by Application (2016-2021)
Table 84. Japan Oral Mucositis Drugs Sales by Application (2022-2027) & (K Units)
Table 85. Japan Oral Mucositis Drugs Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Oral Mucositis Drugs Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Oral Mucositis Drugs Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Oral Mucositis Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Oral Mucositis Drugs Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Oral Mucositis Drugs Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Oral Mucositis Drugs Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Oral Mucositis Drugs Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Oral Mucositis Drugs Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Oral Mucositis Drugs Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Oral Mucositis Drugs Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Oral Mucositis Drugs Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Oral Mucositis Drugs Sales Market Share by Application (2022-2027)
Table 98. India Oral Mucositis Drugs Sales (K Units) by Company (2016-2021)
Table 99. India Oral Mucositis Drugs Sales Market Share by Company (2016-2021)
Table 100. India Oral Mucositis Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Oral Mucositis Drugs Revenue Market Share by Company (2016-2021)
Table 102. India Oral Mucositis Drugs Sales by Type (2016-2021) & (K Units)
Table 103. India Oral Mucositis Drugs Sales Market Share by Type (2016-2021)
Table 104. India Oral Mucositis Drugs Sales by Type (2022-2027) & (K Units)
Table 105. India Oral Mucositis Drugs Sales Market Share by Type (2022-2027)
Table 106. India Oral Mucositis Drugs Sales by Application (2016-2021) & (K Units)
Table 107. India Oral Mucositis Drugs Sales Market Share by Application (2016-2021)
Table 108. India Oral Mucositis Drugs Sales by Application (2022-2027) & (K Units)
Table 109. India Oral Mucositis Drugs Sales Market Share by Application (2022-2027)
Table 110. 3M Healthcare Corporation Information
Table 111. 3M Healthcare Description and Business Overview
Table 112. 3M Healthcare Oral Mucositis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. 3M Healthcare Oral Mucositis Drugs Product
Table 114. 3M Healthcare Recent Development
Table 115. GSK Corporation Information
Table 116. GSK Description and Business Overview
Table 117. GSK Oral Mucositis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. GSK Oral Mucositis Drugs Product
Table 119. GSK Recent Development
Table 120. Pfizer Corporation Information
Table 121. Pfizer Description and Business Overview
Table 122. Pfizer Oral Mucositis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Pfizer Oral Mucositis Drugs Product
Table 124. Pfizer Recent Development
Table 125. Colgate-Palmolive Corporation Information
Table 126. Colgate-Palmolive Description and Business Overview
Table 127. Colgate-Palmolive Oral Mucositis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Colgate-Palmolive Oral Mucositis Drugs Product
Table 129. Colgate-Palmolive Recent Development
Table 130. Norgine Corporation Information
Table 131. Norgine Description and Business Overview
Table 132. Norgine Oral Mucositis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Norgine Oral Mucositis Drugs Product
Table 134. Norgine Recent Development
Table 135. Sobi Corporation Information
Table 136. Sobi Description and Business Overview
Table 137. Sobi Oral Mucositis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Sobi Oral Mucositis Drugs Product
Table 139. Sobi Recent Development
Table 140. Bausch Health Corporation Information
Table 141. Bausch Health Description and Business Overview
Table 142. Bausch Health Oral Mucositis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Bausch Health Oral Mucositis Drugs Product
Table 144. Bausch Health Recent Development
Table 145. EUSA Pharma Corporation Information
Table 146. EUSA Pharma Oral Mucositis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. EUSA Pharma Description and Business Overview
Table 148. EUSA Pharma Oral Mucositis Drugs Product
Table 149. EUSA Pharma Recent Development
Table 150. Camurus Corporation Information
Table 151. Camurus Oral Mucositis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Camurus Description and Business Overview
Table 153. Camurus Oral Mucositis Drugs Product
Table 154. Camurus Recent Development
Table 155. Clinigen Group Corporation Information
Table 156. Clinigen Group Description and Business Overview
Table 157. Clinigen Group Oral Mucositis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Clinigen Group Oral Mucositis Drugs Product
Table 159. Clinigen Group Recent Development
Table 160. Helsinn Healthcare Corporation Information
Table 161. Helsinn Healthcare Description and Business Overview
Table 162. Helsinn Healthcare Oral Mucositis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. Helsinn Healthcare Oral Mucositis Drugs Product
Table 164. Helsinn Healthcare Recent Development
Table 165. Alliance Pharma Corporation Information
Table 166. Alliance Pharma Description and Business Overview
Table 167. Alliance Pharma Oral Mucositis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 168. Alliance Pharma Oral Mucositis Drugs Product
Table 169. Alliance Pharma Recent Development
Table 170. Production Base and Market Concentration Rate of Raw Material
Table 171. Key Suppliers of Raw Materials
Table 172. Oral Mucositis Drugs Distributors List
Table 173. Oral Mucositis Drugs Customers List
Table 174. Oral Mucositis Drugs Market Trends
Table 175. Oral Mucositis Drugs Market Drivers
Table 176. Oral Mucositis Drugs Market Challenges
Table 177. Oral Mucositis Drugs Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Mucositis Drugs Product Picture
Figure 2. Global Oral Mucositis Drugs Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Oral Mucositis Drugs Sales Market Share by Application in 2021 & 2027
Figure 6. Chemotherapy Examples
Figure 7. Radiotherapy Examples
Figure 8. Global Oral Mucositis Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Oral Mucositis Drugs Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Oral Mucositis Drugs Sales (K Units) Growth Rate (2016-2027)
Figure 11. Global Oral Mucositis Drugs Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 12. Global Oral Mucositis Drugs Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Oral Mucositis Drugs Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Oral Mucositis Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Oral Mucositis Drugs Sales (K Units) Growth Rate (2016-2027)
Figure 16. Europe Oral Mucositis Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Oral Mucositis Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Oral Mucositis Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Oral Mucositis Drugs Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Oral Mucositis Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Oral Mucositis Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Oral Mucositis Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Oral Mucositis Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Oral Mucositis Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Oral Mucositis Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Oral Mucositis Drugs Players Market Share by Revenue in Oral Mucositis Drugs: 2016 & 2020
Figure 27. Oral Mucositis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Oral Mucositis Drugs Revenue Share by Type (2016-2021)
Figure 29. Global Oral Mucositis Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Oral Mucositis Drugs Revenue Share by Application (2016-2021)
Figure 31. Global Oral Mucositis Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Oral Mucositis Drugs Sales Market Share by Type in 2020
Figure 33. North America Oral Mucositis Drugs Sales Market Share by Application in 2020
Figure 34. Europe Oral Mucositis Drugs Sales Market Share by Type in 2020
Figure 35. Europe Oral Mucositis Drugs Sales Market Share by Application in 2020
Figure 36. China Oral Mucositis Drugs Sales Market Share by Type in 2020
Figure 37. China Oral Mucositis Drugs Sales Market Share by Application in 2020
Figure 38. Japan Oral Mucositis Drugs Sales Market Share by Type in 2020
Figure 39. Japan Oral Mucositis Drugs Sales Market Share by Application in 2020
Figure 40. Southeast Asia Oral Mucositis Drugs Sales Market Share by Type in 2020
Figure 41. Southeast Asia Oral Mucositis Drugs Sales Market Share by Application in 2020
Figure 42. India Oral Mucositis Drugs Sales Market Share by Type in 2020
Figure 43. India Oral Mucositis Drugs Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Oral Mucositis Drugs
Figure 46. Manufacturing Process Analysis of Oral Mucositis Drugs
Figure 47. Oral Mucositis Drugs Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
世界のIV＆経口鉄剤市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global IV and Oral Iron Drugs Market The global IV and Oral Iron Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the repo…- 世界の経口抗糖尿病薬市場規模・現状・予測（2021年-2027年） Diabetes is a chronic disease that occurs when the body cannot effectively use the produced insulin or the pancreas does not produce sufficient insulin. The pancreas is an organ that sits behind the stomach and releases hormones into the digestive system. Diabetes is categorized by increased levels …
- 世界の化学療法誘発性血小板減少症治療薬市場規模・現状・予測（2021年-2027年） Chemotherapy is the cancer treatment given to patients with different forms of the cancer. Various drugs such as alkylating agents, antimetabolites, targeted therapy, immunotherapy drugs, etc. are used for the cancer treatment. These chemotherapy agents acts against the cancerous as well as normal c…
- 世界の掻痒治療薬市場規模・現状・予測（2021年-2027年） Transdermal drug delivery systems are the most preferred methods of delivering pruritus drugs. The majority of the pruritus drugs are available in semi-solid topical dosage forms, such as lotions, gels, and creams, which are easier to apply, are less painful, and provides faster action than other fo…
- 世界の脊髄性筋萎縮症（SMA）治療薬市場規模・現状・予測（2021年-2027年） Spinal Muscular Atrophy (SMA), also known as spinal muscular atrophy, is a type of disease in which the degeneration of motor neurons in the anterior horn of the spinal cord leads to muscle weakness and muscular atrophy.The Spinal muscular atrophy drugs Can effectively alleviate the symptoms of the …